Zobrazeno 1 - 10
of 32
pro vyhledávání: '"R.-M. Lederle"'
Autor:
D. Kikis, A. Steinmetz, H.-R. Arntz, A. Overlack, H. U. Klör, W. Kirch, R.-M. Lederle, K. O. Stumpe, G. Bönner
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 116:7-12
The efficacy and safety of pravastatin and bezafibrate (in retard form) were compared in a randomised double-blind trial comprising 96 patients (48 men, 48 women; mean age 52.5 [20-68] years) with primary hypercholesterolaemia types IIa and IIb. Afte
Autor:
R. M. Lederle
Publikováno v:
Journal of Cardiovascular Pharmacology. 20:69-72
The course and prognosis of chronic renal failure are much worse in hypertensive patients than in normotensive patients with otherwise similar basic disease. Therefore, antihypertensive measures with a combination of diuretics, β-blockers, and vasod
Publikováno v:
Journal of Cardiovascular Pharmacology. 18:S48-S50
Autor:
A, Overlack, M, Adamczak, W, Bachmann, G, Bönner, R G, Bretzel, R, Derichs, W, Krone, R M, Lederle, H J, Reimann, H, Zschiedrich
Publikováno v:
The American journal of medicine. 97(2)
Many hypertensive patients have other, usually long-term diseases. Antihypertensive therapy may interfere with these diseases and their therapies. In the present study, the possible interactions of the ACE-inhibitor perindopril with several of the mo
Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy
Publikováno v:
Arzneimittel-Forschung. 43(8)
Angiotensin-converting enzyme (ACE) inhibitors are well established antihypertensives. Their effect on kidney function, however, seems to depend on the pathophysiological mechanisms underlying the clinical symptoms. In one part of the Perindopril and
Autor:
R M, Lederle
Publikováno v:
Fortschritte der Medizin. 109(30)
An open multicenter trial involving 7,232 participating physicians, was performed to assess the anti-hypertensive efficacy and tolerance of a fixed combination of captopril and hydrochlorothiazide (Capozide) given once daily to 34,976 patients (mean
Autor:
H R, Arntz, G, Bönner, D, Kikis, W, Kirch, H U, Klör, R M, Lederle, A, Overlack, A, Steinmetz, K O, Stumpe
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 116(1)
The efficacy and safety of pravastatin and bezafibrate (in retard form) were compared in a randomised double-blind trial comprising 96 patients (48 men, 48 women; mean age 52.5 [20-68] years) with primary hypercholesterolaemia types IIa and IIb. Afte
Autor:
H V, Gärtner, P, Arck, M, Hanatani, N, Settgast, R, Wanninger, R M, Lederle, C, Erley, E, Mikeler
Publikováno v:
Verhandlungen der Deutschen Gesellschaft fur Pathologie. 75
A pathogenetic relationship is postulated for the development of membranoproliferative glomerulonephritis type I in non-Hodgkin's lymphoma (B-cell lymphoma of low-grade malignancy) and myeloproliferative syndrome, which we have observed in eight pati
Autor:
R. M. Lederle, D. Klaus
Publikováno v:
Clinical and Experimental Hypertension. Part A: Theory and Practice. 9:155-213
Publikováno v:
Klinische Wochenschrift. 62:753-758
We observed a 23-year-old man with pronounced hyperkalemia (max. 6.8 mmol/l) and hyponatremia (min. 112 mmol/l), which had been existent for 3 years without complaint except a transitory psychorganic syndrome due to hyponatremia. Physical examination